RC25
Retatrutide 20mg + Cagrilintide 5mg
This co-formulated lyophilized powder is available in a pack of ten 25mg vials.
Highlights
- Co-formulated lyophilized solid.
- Single 25mg vial size.
- Includes certificate of analysis.
Typical research applications
- Research standard preparation.
- Assay validation material.
Lot and handling notes
The product is a sterile, white lyophilized cake contained within sealed vials. Each vial contains the specified 20mg and 5mg combination for research use.
A complete certificate of analysis is supplied with every order. This material is intended solely for laboratory research purposes.
Specifications
| Product | |
|---|---|
| Abbreviation | RC25 |
| Form | Lyophilized material |
| Pack sizes | 25mg*10vials |
| Analysis | |
| Measured content | 25mg: Retatrutide 21.94MG + Cagrilintide 5.70mg |
| Documentation | |
| Lot record | Supplied with every order |